neupogen
(Filgrastim)Amgen Inc
Usage: NEUPOGEN is indicated for reducing infection risk in cancer patients receiving myelosuppressive chemotherapy, accelerating neutrophil recovery in acute myeloid leukemia, decreasing neutropenia duration in bone marrow transplant patients, mobilizing progenitor cells for collection, treating severe chronic neutropenia, and enhancing survival after myelosuppressive radiation exposure.